Evolent announces key appointments to leadership team
Evolent Health (NYSE: EVH) announced two key leadership appointments to strengthen its clinical and financial teams.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Evolent Health (NYSE: EVH) announced two key leadership appointments to strengthen its clinical and financial teams. Dr. David Lim joins as chief clinical officer, bringing extensive experience in value-based care and healthcare technology. He will lead Evolent's 300-person medical team and report to CMO Dr. Von Nguyen.
John Way has been appointed as CFO of Performance Suite, overseeing financial aspects of the company's at-risk specialty condition management products. Way brings over 20 years of executive financial experience, including roles as CFO at OptumHealth and OptumCare, and will report to CFO John Johnson.
Details
News Market Reaction – EVH
The recorded move for EVH in the trading session of this news was -4.16%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Dr. David Lim joins Evolent as chief clinical officer
- John Way joins Evolent as CFO, Performance Suite
Physician, executive and startup entrepreneur Dr. David Lim has joined the company as chief clinical officer, where he will lead Evolent's 300-person medical team to support daily operations and innovation. Dr. Lim brings deep experience in value-based care, technology-enabled healthcare and patient engagement. Before joining Evolent, he served as chief medical officer (CMO) of RightMove Health, a virtual physical therapy company he helped to grow from the ground up as its first employee. Dr. Lim has also served as chief technology innovation officer for value-based care company InnovaCare Health, founding team member and CMO of behavioral health company Quartet Health, and director of clinical design for Castlight Health, which provided healthcare services cost and quality data to members of self-insured employers.
Additionally, John Way has joined Evolent as CFO, Performance Suite, where he will oversee all financial aspects of the company's at-risk specialty condition management products. Mr. Way brings more than 20 years of executive financial management experience to the role, including as CFO of OptumHealth and OptumCare. He combines deep subject matter expertise in risk-based value arrangements with an innovator's perspective to drive success for Evolent and its partners.
"I'm excited to welcome Dave and John, not just because of their deep experience but also their commitment to transforming specialty care for patients, payers and providers," said Evolent CEO and Co-Founder Seth Blackley. "As these additions show, Evolent remains a leading destination for talented and accomplished leaders in our field."
Dr. Lim will report to Chief Medical Officer Dr. Von Nguyen, while Mr. Way will report to CFO John Johnson.
About Evolent
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolent.com.
Media inquiries
View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-announces-key-appointments-to-leadership-team-302500645.html
SOURCE Evolent Health, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.